{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:54Z","timestamp":1792511994696,"version":"4.5.0"},"reference-count":19,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"Sp. 2","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["Biomed."],"abstract":"<jats:p>El STAT1 (Signal Transducer and Activator of Transcription 1) es un factor de transcripci\u00f3n citoplasm\u00e1tico, cuya funci\u00f3n es la regulaci\u00f3n del crecimiento, la diferenciaci\u00f3n, la proliferaci\u00f3n, el metabolismo y la apoptosis celular. La v\u00eda de se\u00f1alizaci\u00f3n JAK\/STAT, mediada por el interfer\u00f3n, participa en la eliminaci\u00f3n de agentes pat\u00f3genos intracelulares y virus.Las variantes pat\u00f3genas de STAT1 pueden producir una funci\u00f3n deficiente o incrementada. El aumento de la funci\u00f3n o actividad del factor de transcripci\u00f3n STAT1, descrito en el 2011, ocurre por su fosforilaci\u00f3n excesiva. Los portadores de estas variantes patog\u00e9nicas pueden desarrollar enfermedades autoinmunitarias e inflamatorias, y son susceptibles a infecciones por hongos, virus y bacterias. La manifestaci\u00f3n temprana y com\u00fan es la candidiasis mucocut\u00e1nea cr\u00f3nica.Este reporte trata sobre un paciente, en cuyo primer a\u00f1o de vida, se manifest\u00f3 un aumento de la funci\u00f3n del factor STAT1. Actualmente, tiene 27 a\u00f1os, ha presentado infecci\u00f3n por el bacilo de Calmette-Gu\u00e9rin y Mycobacterium tuberculosis, candidiasis mucocut\u00e1nea cr\u00f3nica, ti\u00f1a de la cabeza (tinea capitis), y ros\u00e1cea facial y ocular. Se descart\u00f3 infecci\u00f3n por HIV. Por las manifestaciones cl\u00ednicas, se sospech\u00f3 un error innato de la inmunidad, espec\u00edficamente, con aumento de la funci\u00f3n o actividad del STAT1. El diagn\u00f3stico se corrobor\u00f3 con la secuenciaci\u00f3n de m\u00faltiples genes asociados con errores innatos de la inmunidad. En este paciente, se hall\u00f3 la variante patog\u00e9nica c.961A&gt;G (p.Arg321Gly) en el gen STAT1, previamente reportada como una mutaci\u00f3n de aumento de la funci\u00f3n.<\/jats:p>","DOI":"10.7705\/biomedica.7521","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:50:52Z","timestamp":1736437852000},"page":"22-30","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Candidiasis mucocut\u00e1nea cr\u00f3nica, infecciones micobacterianas y ros\u00e1cea en un adulto mexicano con aumento de la funci\u00f3n en STAT1","Chronic mucocutaneous candidiasis, mycobacterial infections and rosacea in a Mexican adult with STAT1 gain of function"],"prefix":"10.7705","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1292-1439","authenticated-orcid":false,"given":"Valeria","family":"Valerio-G\u00f3mez","sequence":"first","affiliation":[{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2156-2166","authenticated-orcid":false,"given":"Uriel","family":"P\u00e9rez-Blanco","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatr\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatr\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8247-4300","authenticated-orcid":false,"given":"Guillermo","family":"Vel\u00e1zquez-S\u00e1mano","sequence":"additional","affiliation":[{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-1906","authenticated-orcid":false,"given":"Andrea A\u00edda","family":"Velasco-Medina","sequence":"additional","affiliation":[{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3259-0626","authenticated-orcid":false,"given":"Antonio","family":"Albarr\u00e1n","sequence":"additional","affiliation":[{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4605-7902","authenticated-orcid":false,"given":"Itzel Yosel\u00edn","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Servicio de Alergia e Inmunolog\u00eda, Hospital General de M\u00e9xico \u201cDr. Eduardo Liceaga\u201d, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3290-8705","authenticated-orcid":false,"given":"Laura","family":"Berr\u00f3n-Ruiz","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatr\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatr\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4859-3151","authenticated-orcid":false,"given":"Sara","family":"Espinosa-Padilla","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatr\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatr\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3861-8864","authenticated-orcid":false,"given":"Lizbeth","family":"Blancas-Galicia","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatr\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"},{"name":"Laboratorio de Inmunodeficiencias, Instituto Nacional de Pediatr\u00eda, Ciudad de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"141623","doi-asserted-by":"crossref","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: From bench to clinic. Signal Transduct Target Ther. 2021;6:402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1","DOI":"10.1038\/s41392-021-00791-1"},{"key":"141624","doi-asserted-by":"crossref","unstructured":"Luo Y, Alexander M, Gadina M, O\u2019Shea JJ, Meylan F, Schwartz DM, et al. JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition. J Allergy Clin Immunol. 2021;148:911-25. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.004","DOI":"10.1016\/j.jaci.2021.08.004"},{"key":"141625","doi-asserted-by":"crossref","unstructured":"Okada S, Asano T, Moriya K, Boisson-Dupuis S, Kobayashi M, Casanova JL. Human STAT1 gain-of-function heterozygous mutations: Chronic mucocutaneous candidiasis and type I interferonopathy. J Clin Immunol. 2020;40:1065-81. https:\/\/doi.org\/ 10.1007\/s10875-020-00847-x","DOI":"10.1007\/s10875-020-00847-x"},{"key":"141626","doi-asserted-by":"crossref","unstructured":"Asano T, Utsumi T, Kagawa R, Karakawa S, Okada S. Inborn errors of immunity with lossand gain-of-function germline mutations in STAT1. Clin Exp Immunol. 2023;212:96-106. https:\/\/doi.org\/10.1093\/cei\/uxac106","DOI":"10.1093\/cei\/uxac106"},{"key":"141627","doi-asserted-by":"crossref","unstructured":"Bousfiha A, Moundir A, Tangye SG, Picard C, Jeddane L, Al-Herz W, et al. The 2022 Update of IUIS Phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022;42:1508-20. https:\/\/doi.org\/10.1007\/s10875-022-01352-z","DOI":"10.1007\/s10875-022-01352-z"},{"key":"141628","doi-asserted-by":"crossref","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Lagos-G\u00f3mez M, Aldave-Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127:3154-64. https:\/\/doi.org\/10.1182\/blood-2015-11-679902","DOI":"10.1182\/blood-2015-11-679902"},{"key":"141629","doi-asserted-by":"crossref","unstructured":"Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, et al. The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1. J Clin Immunol. 2016;36:73-84. https:\/\/doi.org\/10.1007\/s10875-015-0214-9","DOI":"10.1007\/s10875-015-0214-9"},{"key":"141630","doi-asserted-by":"crossref","unstructured":"Zhang W, Chen X, Gao G, Xing S, Zhou L, Tang X, et al. Clinical relevance of gain- and loss-of-function germline mutations in STAT1: A systematic review. Front Immunol. 2021;12:654406. https:\/\/doi.org\/10.3389\/fimmu.2021.654406","DOI":"10.3389\/fimmu.2021.654406"},{"key":"141631","doi-asserted-by":"crossref","unstructured":"Pedraza-S\u00e1nchez S, M\u00e9ndez-Le\u00f3n JI, Gonz\u00e1lez Y, Ventura-Ayala ML, Herrera MT, Lezana-Fern\u00e1ndez JL, et al. Oral administration of human polyvalent IgG by mouthwash as an adjunctive treatment of chronic oral candidiasis. Front Immunol. 2018;9:2956. https:\/\/doi.org\/10.3389\/fimmu.2018.02956","DOI":"10.3389\/fimmu.2018.02956"},{"key":"141632","doi-asserted-by":"crossref","unstructured":"Luis BAL, Calva-Mercado JJ. Recurrent spontaneous intestinal perforation due to STAT1- GOF mutation. Am J Gastroenterol. 2018;113:1057-8. https:\/\/doi.org\/10.1038\/s41395-018-0089-5","DOI":"10.1038\/s41395-018-0089-5"},{"key":"141633","doi-asserted-by":"crossref","unstructured":"Pedraza-S\u00e1nchez S, Lezana-Fern\u00e1ndez JL, Gonz\u00e1lez Y, Mart\u00ednez-Robles L, Ventura-Ayala ML, Sadowinski-Pine S, et al. Disseminated tuberculosis and chronic mucocutaneous candidiasis in a patient with a gain-of-function mutation in signal transduction and activator of transcription 1. Front Immunol. 2017;8:1651. https:\/\/doi.org\/10.3389\/fimmu.2017.01651","DOI":"10.3389\/fimmu.2017.01651"},{"key":"141634","doi-asserted-by":"crossref","unstructured":"Staines-Boone AT, Vignesh P, Tsumura M, de la Garza-Fern\u00e1ndez G, Tyagi R, Rawat A, et al. Fatal COVID-19 infection in two children with STAT1 gain-of-function. J Clin Immunol. 2023;44:20. https:\/\/doi.org\/10.1007\/s10875-023-01634-0","DOI":"10.1007\/s10875-023-01634-0"},{"key":"141635","doi-asserted-by":"crossref","unstructured":"Saez-de-Ocariz M, Su\u00e1rez-Guti\u00e9rrez M, Migaud M, Farrill-Romanillos PO, Casanova JL, Segura-M\u00e9ndez NH, et al. Rosacea as a striking feature in family members with a STAT1 gain-of-function mutation. J Eur Acad Dermatol Venereol. 2020;34:e265-7. https:\/\/doi.org\/10.1111\/jdv.16241","DOI":"10.1111\/jdv.16241"},{"key":"141636","doi-asserted-by":"crossref","unstructured":"Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208:1635-48. https:\/\/doi.org\/10.1084\/jem.20110958","DOI":"10.1084\/jem.20110958"},{"key":"141637","doi-asserted-by":"crossref","unstructured":"Ahn CS, Huang WW. Rosacea pathogenesis. Dermatol Clin. 2018;36:81-6. https:\/\/doi.org\/10.1016\/j.det.2017.11.001","DOI":"10.1016\/j.det.2017.11.001"},{"key":"141638","doi-asserted-by":"crossref","unstructured":"Ma Y, Wang X, Li R. AIRE gene mutation predisposing chronic mucocutaneous candidiasis and pigmented retinitis in two kids from a Chinese family. Emerg Microbes Infect. 2022;11:1705-6. https:\/\/doi.org\/10.1080\/22221751.2022.2090860","DOI":"10.1080\/22221751.2022.2090860"},{"key":"141639","doi-asserted-by":"crossref","unstructured":"Dey\u00e0-Mart\u00ednez A, Rivi\u00e8re JG, Roxo-Junior P, Ramakers J, Bloomfield M, Guisado HP, et al. Impact of JAK inhibitors in pediatric patients with STAT1 gain-of-function (GOF) mutations\u201410 children and review of the literature. J Clin Immunol. 2022;42:1071-1082. https:\/\/doi.org\/10.1007\/s10875-022-01257-x","DOI":"10.1007\/s10875-022-01257-x"},{"key":"141640","doi-asserted-by":"crossref","unstructured":"Bloomfield M, Kanderov\u00e1 V, Para\u010dkov\u00e1 Z, Vrabcov\u00e1 P, Svato\u0148 M, Fro\u0148kov\u00e1 E, et al. Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gainof-function mutation. J Clin Immunol. 2018;38:589-601. https:\/\/doi.org\/10.1007\/s10875-018-0519-6","DOI":"10.1007\/s10875-018-0519-6"},{"key":"141641","doi-asserted-by":"crossref","unstructured":"Forbes LR, Vogel TP, Cooper MA, Castro-Wagner J, Schussler E, Weinacht K, et al. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. J Allergy Clin Immunol. 2018;142:1665-9. https:\/\/doi.org\/10.1016\/j.jaci.2018.07.020","DOI":"10.1016\/j.jaci.2018.07.020"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7521\/5606","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7521\/5730","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/7521\/5606","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:16:29Z","timestamp":1773321389000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/7521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":19,"journal-issue":{"issue":"Sp. 2","published-online":{"date-parts":[[2024,12,23]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.7521","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"2024-12-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Presentaci\u00f3n de caso","name":"content_type","label":"Content Type"}]}}